XNAS · Healthcare · Diagnostics & Research
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | Q1 2026 | -2.17 | -2.29 | -5.53% | $39.8M | ❌ Miss | -1.10% | +13.93% | — |
| 2026-02-19 | Q4 2025 | -2.93 | -2.44 | +16.72% | $43.6M | ✅ Beat | -48.54% | -42.78% | -53.87% |
| 2025-11-12 |
| Q3 2025 |
| -3.36 |
| -2.46 |
| +26.79% |
| $36.2M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-12 | Q2 2025 | -3.39 | -3.18 | +6.19% | $35.5M | ✅ Beat | -1.79% | -6.49% | +15.03% |
| 2025-02-20 | Q4 2024 | — | -2.89 | — | $38.3M | — | -14.72% | -17.75% | -32.73% |
| 2024-08-13 | Q2 2024 | — | -5.30 | — | $32.0M | — | -2.84% | +1.39% | -14.46% |
Showing last 6 quarters.